Pregnancy among women with congenitally corrected transposition of great arteries  by Connolly, Heidi M et al.
Adult Congenital Heart Disease
Pregnancy Among Women With Congenitally
Corrected Transposition of Great Arteries
Heidi M. Connolly, MD, FACC, Martha Grogan, MD, FACC, Carole A. Warnes, MD, MRCP, FACC
Rochester, Minnesota
OBJECTIVES The outcome of pregnancy in congenitally corrected transposition of the great vessels was
studied in 22 women.
BACKGROUND Women with congenitally corrected transposition of the great vessels often reach childbearing
age. Although reports on the outcome of pregnancy in these women are available, the number
of patients is small.
METHODS The medical and surgical databases at the Mayo Clinic were reviewed, and 36 women .16
years old with congenitally corrected transposition of the great vessels were identified. All of
them were contacted, and 22 who had pregnancies were identified and the outcome of
pregnancy was evaluated.
RESULTS Twenty-two women had 60 pregnancies resulting in 50 live births (83%). Forty-four
deliveries (88%) were vaginal and 6 (12%) were by cesarean section. One delivery was
premature at 29 weeks. There was one successful twin pregnancy. There were 11 unsuccessful
pregnancies. One patient developed congestive heart failure late in pregnancy because of
systemic atrioventricular valve regurgitation and required valve replacement in the early
postpartum period. One patient had a total of 12 pregnancies, including 1 twin pregnancy and
2 unsuccessful pregnancies. She had multiple pregnancy-related complications, including
toxemia, congestive heart failure, endocarditis and myocardial infarction (single coronary
artery). No other serious pregnancy-related maternal complications and no pregnancy-related
deaths occurred. The mean birth weight of the infants (n 5 32) was 3.2 6 0.4 kg. None of
the 50 live offspring have been diagnosed with congenital heart disease.
CONCLUSIONS Successful pregnancy can be achieved in most women with congenitally corrected transpo-
sition of the great arteries. The rate of fetal loss and maternal cardiovascular morbidity is
increased. Because of the small number of births, the risk of congenital heart disease in
offspring of women with congenitally corrected transposition of the great arteries is uncertain.
(J Am Coll Cardiol 1999;33:1692–5) © 1999 by the American College of Cardiology
Congenitally corrected transposition of the great arteries
(l-TGA) is an uncommon form of congenital heart disease
that accounts for ,1% of all congenital cardiac defects (1)
and is characterized by atrioventricular and ventricular–
great arterial discordance. Although l-TGA may occur as an
isolated congenital anomaly (2), it usually is associated with
other congenital abnormalities (3,4), including ventricular
septal defect, pulmonary stenosis (valvular or subvalvular),
anomalies of the atrioventricular valves (Ebstein-like mal-
formation of the systemic atrioventricular valve), complete
heart block, dextrocardia and (less commonly) atrial septal
defect. Often, patients with isolated l-TGA are initially
identified during adult life. Survival into adulthood is
common, either after operation (5,6) or with isolated
l-TGA. From 30% to 50% of patients with l-TGA have
systemic ventricular dysfunction and systemic atrioventric-
ular valve regurgitation, because the morphologic right
ventricle and tricuspid valve are in the systemic circulation
(7,8).
The outcome of pregnancy in l-TGA has been described
(2,9,10), but no pregnancy series has been reported in such
patients. To better define the maternal and fetal outcome of
pregnancy in women with l-TGA, we reviewed the Mayo
Clinic records of 36 such women.
METHODS
The medical and surgical databases of the Mayo Clinic were
reviewed, and 36 women of childbearing age (.16 years)
with l-TGA who were evaluated at the Mayo Clinic in the
last 17 years (1980 to 1997) were identified. The patients
were evaluated either in follow-up by one of the authors or
contacted through the mail or by telephone. Their medical
records were reviewed. Twenty-two women who had preg-
nancies were identified. A detailed obstetric history that
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included details of menstrual history, pregnancy, delivery
and fetal outcome was obtained from each woman. Corre-
spondence from local obstetricians and cardiologists was
reviewed; however, these physicians were not contacted
directly.
The clinical, surgical and diagnostic (electrocardiography,
chest radiography and echocardiography) data were re-
viewed for each patient. All patients had the diagnosis of
l-TGA confirmed by one or more of the following: com-
prehensive echocardiographic examination, cardiac cathe-
terization and surgical intervention. Congenital cardiac
surgery was performed in nine women before pregnancy and
in eight women after pregnancy.
Fourteen women with l-TGA have not had a pregnancy
and in none of them has pregnancy been contraindicated.
Eight women who were advised against pregnancy subse-
quently became pregnant. They had 11 pregnancies, and 10
were successful. None of the women in the present series
reported infertility.
Statistical methods. Pregnancy and birth weight variables
were compared between women who previously had surgical
intervention for l-TGA and those who had not. Mean
values 6 standard deviations were calculated for continuous
variables and evaluated for statistical significance by a
two-sample t test. Absolute and relative frequencies were
measured for discrete variables and evaluated with the
Fisher exact test. A p value , 0.05 was considered statisti-
cally significant.
RESULTS
Twenty-two women with l-TGA had 60 pregnancies (Fig.
1). The mean maternal age at the time of delivery was
28.6 6 5.6 years (range, 19 years to 45 years). Four women
had isolated l-TGA and 18 had associated anomalies.
Associated cardiac anomalies included ventricular septal
defect in 10 women, pulmonary valve or subvalvular stenosis
in 7, atrial septal defect or patent foramen ovale in 6,
dextrocardia in 5, and straddling systemic atrioventricular
valve, Ebstein-like systemic atrioventricular valve and a
single coronary artery in one each. Congenital heart disease
has not been identified in any of the live offspring. The
unsuccessful pregnancies were not evaluated for congenital
anomalies.
Of the 22 women, 9 had 1 or more cardiovascular
procedures (4 had reoperation) before pregnancy. All of
these women had significant coexistent cardiovascular dis-
ease. The procedures performed included ventricular septal
defect closure in 7 women, conduit placement in 5 (1
conduit re-replacement), atrial septal defect closure in 3,
systemic atrioventricular valve replacement in 2, Blalock-
Taussig shunt placement in 2, and pulmonary artery band
and permanent pacemaker implantation in 1 each.
After pregnancy, 10 women had 1 or more cardiovascular
procedures. Two operations were performed within 6
months after delivery; these included 1 atrioventricular valve
replacement and 1 atrial septal defect closure. Other inter-
ventions were performed a mean of 16 years after pregnancy
(range, 2 months to 41 years) and included valve replace-
ment, atrial septal defect closure, permanent pacemaker
implantation, ventricular septal defect closure, percutaneous
transluminal coronary angioplasty and cardiac transplanta-
tion.
Pregnancy outcome. Overall, 50 of the 60 pregnancies
(83%) were successful, including one twin pregnancy. There
were 8 miscarriages (first trimester), two spontaneous abor-
tions (second trimester), and 1 stillbirth in 6 women. Of the
50 deliveries, 44 (88%) were vaginal and 6 (12%) were by
cesarean section (Fig. 1). Three of the cesarean sections
were performed for obstetric reasons and the other three for
perceived maternal cardiovascular risk. There were no
pregnancy-related maternal deaths; however, one woman
developed congestive heart failure late during pregnancy
because of systemic atrioventricular valve regurgitation
(ejection fraction, 45%). This patient required atrioventric-
ular valve replacement two months’ postpartum. One pa-
tient developed hypertension and gestational diabetes dur-
ing pregnancy. Another woman, who had 12 pregnancies,
had multiple pregnancy-related complications, including
congestive heart failure, toxemia, endocarditis and a myo-
cardial infarction (single coronary artery).
The mean birth weight of 32 infants born to women with
l-TGA was 3.2 6 0.4 kg. The mean birth weight of nine
infants born to women who had undergone a previous
cardiac operation was significantly lower than that of 23
infants born to women who had no previous cardiac
operation (2.8 6 0.5 kg vs. 3.3 6 0.4 kg) (p 5 0.006). Birth
weights were not available for 18 infants.
Pregnancy in women with a previous cardiovascular
procedure. Nine women had pregnancies after one or more
cardiovascular procedures for l-TGA and associated anom-
alies. There were 29 pregnancies, 27 of which were success-
ful. Seven women had previous ventricular septal defect
closure, 5 had simultaneous conduit placement from the
right ventricle to the pulmonary artery, and 1 had conduit
replacement for conduit obstruction. Three women had
atrial septal defects closed, 2 had systemic atrioventricular
Figure 1. Results of 60 pregnancies in women with congenitally
corrected transposition of the great vessels. There were no thera-
peutic abortions.
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valves replaced (1 Ionescu-Shiley and 1 Carpentier-
Edwards), 2 had a prior Blalock-Taussig shunt, 1 had a
pulmonary artery band and 1 had a permanent pacemaker
implanted before pregnancy. There was no evidence of
premature degeneration of the prosthetic atrioventricular
valves in either patient (follow-up is currently at 3 and 13
years after implantation).
Premature births. There was 1 premature birth (before 38
weeks) among 50 successful pregnancies. The premature
birth occurred at 29 weeks in a woman who had previously
had cardiac surgery (l-TGA associated with ventricular
septal defect, valvular and subvalvular pulmonary stenosis,
type C straddling of the left atrioventricular valve) and was
due to placenta previa.
Unsuccessful pregnancies. Of the 60 pregnancies in
women with l-TGA, 11 were unsuccessful, including 8
miscarriages, 2 spontaneous abortions and 1 stillbirth. The
8 miscarriages occurred in 4 women without previous
cardiac surgery: 2 women subsequently had surgical inter-
vention and 2 still have not had an operation. One miscar-
riage occurred in an acyanotic patient with two previous
operations: initial Blalock-Taussig shunt and subsequent
ventricular septal defect closure and right ventricle-to-
pulmonary artery conduit placement. This patient had atrial
septal defect closure after pregnancy. One spontaneous
abortion occurred in a patient with two previous cardiac
operations: initial ventricular septal defect closure and con-
duit placement from the right ventricle to the pulmonary
artery and subsequent replacement of the conduit because of
conduit obstruction. Seven of the unsuccessful pregnancies
occurred in patients in whom the diagnosis of l-TGA had
not yet been made at the time pregnancy occurred.
DISCUSSION
Significant hemodynamic and physiologic changes occur
during pregnancy (11), some of which may adversely affect
the hemodynamic status of a woman with uncorrected
significant congenital heart disease such as l-TGA. These
changes include an average increase in cardiac output of
40% and an increase in stroke volume, heart rate and
concentration of catecholamines in the circulation. A de-
crease in peripheral vascular resistance is also noted.
Few reports of pregnancy are available about women with
l-TGA (2,9). In the present series, pregnancy was well-
tolerated in all but two women. One woman required
atrioventricular valve replacement in the early postpartum
period. The second had congestive heart failure during three
pregnancies and toxemia, endocarditis and a myocardial
infarction during three other pregnancies. She is alive at age
80 years and recently had percutaneous transluminal coro-
nary angioplasty but no other cardiac surgical intervention.
The rate of cesarean section among the study group was
12% (6 of 50 deliveries), which is lower than the standard
rate of up to 23.5% (National Center for Health Statistics,
1990). The miscarriage rate was 16%, which is somewhat
higher than the expected rate of 10% (12). There was one
stillbirth and two spontaneous abortions. No therapeutic
abortions were performed.
Atrioventricular valve regurgitation and ventricular dys-
function are recognized important complications in patients
with l-TGA, because the morphologic right ventricle and
tricuspid valve are in the systemic circulation (2–8). Among
the women in the present series, one developed symptom-
atic atrioventricular valve regurgitation that required surgi-
cal intervention in the early postpartum period. The diag-
nosis of l-TGA was first made when the patient went into
congestive heart failure postpartum. Another woman had
multiple pregnancy-related complications, including con-
gestive heart failure, endocarditis, toxemia and myocardial
infarction. One woman developed systemic hypertension
and gestational diabetes during pregnancy, and one had a
premature delivery. The significant difference in birth
weight between the offspring of women who had been
operated on and those who had not may reflect the lack of
birth weight data for 18 offspring or differences in the
severity of the disease. None of the women in this series
were cyanotic during pregnancy.
Study limitations. Although the present report is the
largest series describing the outcome of pregnancy in
women with l-TGA, there are several limitations. The study
is retrospective and subject to referral bias. Obstetric details
were obtained directly from each patient and correspon-
dence was reviewed; the obstetricians were not contacted
directly; and birth weights were not available for approxi-
mately one-third of the offspring. The degree of ventricular
dysfunction and atrioventricular valve regurgitation was not
evaluated at this institution during pregnancy. Finally,
because of the small number of offspring of patients with
l-TGA and the lack of formal examination, the incidence of
congenital heart disease in the offspring of patients with
l-TGA remains undetermined.
Conclusions. Most women with l-TGA reach childbear-
ing age. Appropriate evaluation, assessment and recommen-
dations need to be made when these patients wish to pursue
pregnancy. A comprehensive cardiovascular evaluation, in-
cluding an evaluation of cardiac rhythm, systemic ventricu-
lar function, atrioventricular valve function, associated le-
sions and postoperative sequelae, should be performed.
Women with New York Heart Association functional class
III or class IV symptoms, significant systemic ventricular
dysfunction (ejection fraction ,40%) or significant systemic
atrioventricular valve regurgitation should be counseled
against pregnancy.
It is recommended that a pregnant woman with l-TGA
be monitored closely by a multidisciplinary health care team
that includes obstetricians, cardiologists and obstetric anes-
thesiologists. Care must be taken to avoid rapid volume
shifts during pregnancy and parturition. High-risk patients
should be delivered in a monitored setting with Swan-Ganz
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catheterization if appropriate. The second stage of labor
should be facilitated to decrease the excessive hemodynamic
stress on the patient. Endocarditis prophylaxis should be
administered to high-risk patients (13).
The results of this study suggest that l-TGA does not
inhibit fertility in women before or after surgical repair.
Successful pregnancy can be achieved in most women,
although there is increased risk of maternal cardiovascular
morbidity and fetal loss.
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